Ximeceff O 200mg/200mg Tablet is a combination antibiotic formulation containing Cefixime 200mg and Ofloxacin 200mg, designed for the treatment of a broad spectrum of bacterial infections. Cefixime, a third-generation cephalosporin, acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death, while Ofloxacin, a fluoroquinolone, interferes with bacterial DNA gyrase and topoisomerase IV, thereby preventing DNA replication and transcription. This synergistic combination enhances antimicrobial efficacy against both Gram-positive and Gram-negative pathogens, including strains resistant to monotherapy. Ximeceff O is indicated for respiratory tract infections, urinary tract infections, otitis media, gonorrhea, and skin and soft tissue infections caused by susceptible organisms. The tablet should be administered orally as prescribed by a healthcare professional, with dosage adjustments based on infection severity and patient renal function. Caution is advised in patients with a history of hypersensitivity to cephalosporins or fluoroquinolones. Potential side effects include gastrointestinal disturbances, hypersensitivity reactions, and, rarely, tendonitis or tendon rupture associated with fluoroquinolones. It is essential to complete the full course of therapy to prevent resistance development. Ximeceff O should be stored in a cool, dry place away from direct sunlight.